Anteris technologies yesterday announced that the first 5 patients have successfully been implanted with Anteris’s DurAVR Valve.
An additional 5 patients are planned for treatment in the first quarter of 2022 to conclude the study.
This is a massive step towards FDA approval as AVR’s technology shows:
- Avoids the need for open heart surgery
- AVR’s heart valve have shown no calcification over 10 years – therefore avoids repeat surgery, and allows younger patients to be treated
- Early signs from first 5 patients have shown DurAVR providing superior haemodynamics
- Commissural alignment, flow characteristics and haemodynamics were proven to be clinically significant
- Forums
- ASX - By Stock
- Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve
Anteris technologies yesterday announced that the first 5...
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.35 |
Change
0.040(0.22%) |
Mkt cap ! $352.7M |
Open | High | Low | Value | Volume |
$19.00 | $19.00 | $18.13 | $69.15K | 3.766K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 383 | $18.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.50 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 383 | 18.130 |
1 | 300 | 18.110 |
1 | 1000 | 18.000 |
1 | 55 | 17.910 |
2 | 155 | 17.900 |
Price($) | Vol. | No. |
---|---|---|
18.500 | 1000 | 1 |
19.000 | 437 | 1 |
19.700 | 100 | 1 |
19.870 | 202 | 1 |
20.000 | 3400 | 5 |
Last trade - 15.59pm 02/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |